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Abstract
In 2000, chlamydial strains OK133 and OK135 were isolated from 2 female patients with
cervicitis. These strains were unresponsive to commercially available PCR and LCR test kits for
the diagnosis of Chlamydia trachomatis infection, and their phenotypic characteristics were very
similar. The OK135 nucleotide sequence in MOMP-VD2 gene closely resembled that of Chlamy-
dophila caviae GPIC. A similar strain was isolated in 2003 from a male patient OKM2 with ure-
thritis, from which the strain SC10-6 was cloned by the plaque purification method. The nucleotide
sequence of the entire MOMP gene of SC10-6 was exactly the same as that of OK135. Thus, the
strains OK135 and SC10-6, together with OK133, have been called C. caviae-like Chlamydia. We
designed primers for nested PCR assay, the product of which showed a single-band 311-bp frag-
ment, to detect C. caviae-like Chlamydia. Of swab specimens obtained from 202 patients from
2003 to 2006 (119 male and 83 female patients), 18 specimens (8.9%) from 14 male and 4 female
patients were positive, suggesting that C. caviae-like Chlamydia infection is rather common. Thus
far, it has not been determined whether C. caviae-like Chlamydia is pathogenic for humans.
KEYWORDS:Chlamydophila caviae-like Chlamydia, urethra, uterine cervix, epidemiology, sex-
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In 2000,  chlamydial strains OK133 and OK135 were isolated from 2 female patients with cervicitis.  
These strains were unresponsive to commercially available PCR and LCR test kits for the diagnosis of 
Chlamydia trachomatis infection,  and their phenotypic characteristics were very similar.  The OK135 
nucleotide sequence in MOMP-VD2 gene closely resembled that of Chlamydophila caviae GPIC.  A 
similar strain was isolated in 2003 from a male patient OKM2 with urethritis,  from which the strain 
SC10-6 was cloned by the plaque puriﬁcation method.  The nucleotide sequence of the entire MOMP 
gene of SC10-6 was exactly the same as that of OK135.  Thus,  the strains OK135 and SC10-6,  together 
with OK133,  have been called C. caviae-like Chlamydia.  We designed primers for nested PCR assay,  
the product of which showed a single-band 311-bp fragment,  to detect C. caviae-like Chlamydia.  Of 
swab specimens obtained from 202 patients from 2003 to 2006 (119 male and 83 female patients),  18 
specimens (8.9ｵ) from 14 male and 4 female patients were positive,  suggesting that C. caviae-like 
Chlamydia infection is rather common.  Thus far,  it has not been determined whether C. caviae-like 
Chlamydia is pathogenic for humans.
Key words: Chlamydophila caviae-like Chlamydia,  urethra,  uterine cervix,  epidemiology,  sexually transmitted 
infection
pecies of the family Chlamydiaceae are obligate 
intracellular prokaryotic parasites of various 
types of eukaryotic cells including human and animal 
cells.  A unique developmental cycle,  in which chla-
mydial organisms alternate between an infectious ele-
mentary body (EB) and the vegetative reticulate body 
(RB),  distinguishes chlamydial organisms from other 
bacteria [1].  The family Chlamydiaceae includes 2 
genera Chlamydia and Chlamydophila,  and nine species,  
Chlamydia trachomatis,  Chlamydia muridarum,  Chla-
mydia suis,  Chlamydophila pneumoniae,  Chlamydophila 
psittaci,  Chlamydophila pecorum,  Chlamydophila abortus,  
Chlamydophila caviae and Chlamydophila felis [2].  C. 
pneumoniae and C. psittaci are well known as pathogens 
of the respiratory tract.  C. trachomatis,  which was 
originally associated with the ocular disease trachoma,  
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is recognized as the most common pathogen of sexually 
transmitted infections (STIs) including urethritis and 
epididymitis in men,  cervicitis,  urethritis and upper 
genital tract infections in women,  and conjunctivitis 
and pneumonia in newborns.  Complications arising 
from C. trachomatis infection include pelvic inﬂamma-
tory diseases such as ectopic pregnancy and infertility 
in women.  Eﬀorts to reduce the prevalence of infec-
tion with C. trachomatis in both men and women may be 
hampered by the relatively high frequency of asymp-
tomatic patients in both sexes [3].  Due to the diver-
siﬁcation of sexual cultures and behaviors,  the 
increase in STI has become a social problem that can-
not be ignored in Japan [4].
　 A commercially available PCR test kit and a ligase 
chain reaction (LCR) test kit,  both targeting the 7.5-
kb cryptic plasmid common to all members of C. tra-
chomatis,  have been widely used in the diagnosis of 
urogenital C. trachomatis infection in Japan.  The 
results of laboratory experiments have shown that the 
detection limit for both PCR and LCR test kits is just 
two EBs,  and these test kits are highly sensitive and 
speciﬁc [5,  6].  However,  using these test kits alone,  
the biological characteristics of etiologic C. trachoma-
tis strains cannot be analyzed because the isolation and 
propagation of C. trachomatis strains are not required 
in the diagnosis.  Furthermore,  studies have reported 
the presence of C. trachomatis lacking the plasmid [7] 
and STI with plasmid-free C. trachomatis [8-10].  
Moreover,  C. trachomatis strains missing part of the 
nucleic acid sequence in the plasmid were currently 
reported [11].  Hence,  when using only the PCR or 
LCR test kit,  infection caused by C. trachomatis lack-
ing the plasmid and/or missing a plasmid sequence 
would be overlooked.
　 In a preliminary survey of C. trachomatis urogenital 
infection in 2000,  we isolated strains OK133 and 
OK135,  which were unresponsive to PCR and LCR 
test kits,  from female patients with severe cervicitis.  
Their phenotypic characteristics were very similar.  
Genetic analysis of OK135 revealed that the nucle-
otide sequence of the MOMP-VD2 gene closely 
resembled that of C. caviae GPIC.  A strain similar to 
OK135 was more recently isolated from a male patient 
OKM2 with urethritis and cloned as strain SC10-6 by 
the plaque puriﬁcation method [7].  Analysis of the 
entire MOMP gene showed that SC10-6 and OK135 
were identical and closely resembled C. caviae GPIC 
(hereinafter referred to as C. caviae-like Chlamydia).  
In the present paper,  we report an epidemiological 
study of C. caviae-like Chlamydia detected in swab 
specimens collected from the urethra and uterine 
cervix,  using nested PCR with primers especially 
designed in our laboratory.
Materials and Methods
　 Patient specimens and cell cultures for isola-
tion of C. caviae-like Chlamydia. The speci-
mens were obtained from patients with symptoms 
consistent with STI including OK133,  OK135 and 
OKM2 from 2000 to 2006.  Several specimens were 
obtained from female patients who were asymptomatic,  
but anxious to undergo STI examinations.  For female 
genital specimens,  a cotton swab was inserted into the 
endocervical canal and was gently rotated.  For male 
urethral specimens,  a swab was inserted 3 to 4cm 
into the urethra and rotated.  Each swab was placed in 
a test tube containing 0.5ml of sucrose-phosphate-
glutamate (SPG) buﬀer and 0.5g of glass beads (0.5-
mm in diameter),  and then stored at －70℃ until 
testing.  After quickly thawing at 37℃,  a Vortex 
mixer was used to vigorously stir each test tube to 
release the chlamydial organisms from the cotton swab 
with about 1ml of SPG buﬀer (0.5ml in the tube and 
another 0.5ml to wash the beads).  After centrifuging 
at 300×g for 3min at room temperature,  the super-
natant (0.25ml/well) was placed on McCoy cell conﬂu-
ent monolayers in a 24-well culture plate (Corning 
Costar Corp.,  Corning,  NY,  USA),  followed by 
centrifugation (860×g,  25℃,  60min) using a Hitachi 
himac CR21E centrifuge (Hitachi Koki Co.  Ltd.,  
Tokyo,  Japan).  The inoculated cells were then incu-
bated at 37℃ in an atmosphere of 5ｵ CO2 in 
Dulbeccoʼs modiﬁed Eagle medium (DMEM; Nissui,  
Tokyo,  Japan) containing 1µg/ml of cycloheximide,  
10µg/ml of kanamycin,  10µg/ml of vancomycin,  
10µg/ml of amphotericin B and supplemented with 
10ｵ heat-inactivated fetal bovine serum (FBS;  
Gibco BRL,  Life Technologies Inc.,  Grand Island,  
NY,  USA).  Under a phase-contrast microscope,  cell 
conditions were monitored at appropriate intervals,  
and once a cytopathic eﬀect was seen,  the cells were 
suspended in SPG buﬀer (1ml/well) and stored at 
－70℃.
　 Fluorescent and iodine staining. McCoy 
2 Acta Med.  Okayama　Vol.  64,  No.  1Murao et al.
2
Acta Medica Okayama, Vol. 64 [2010], Iss. 1, Art. 1
http://escholarship.lib.okayama-u.ac.jp/amo/vol64/iss1/1
cell monolayers prepared on cover slips (14mm in 
diameter) were inoculated with chlamydial isolates by 
centrifugation and incubated at 37℃.  At 24 to 30h 
post-inoculation,  the cells were ﬁxed with ethanol and 
stained with ﬂuorescein-conjugated monoclonal anti-
body directed against the genus-speciﬁc antigen 
(Chlamydia FA Seiken [DFA stain]; Denka Seiken,  
Tokyo,  Japan) to observe chlamydial inclusions.  To 
check for glycogen accumulation in inclusions,  the 
cover slips harvested at 30h post-inoculation were 
dried and ﬁxed with methanol,  and then subjected to 
iodine staining according to the method of Matsumoto 
et al.  [12].
　 Plaque puriﬁcation. Plaque puriﬁcation was 
carried out according to the method of Matsumoto et 
al.  [7].  Brieﬂy,  100µl of chlamydial suspensions 
prepared in a series of 10-fold dilutions was directly 
added to each well containing 2ml culture medium.  
After suﬃcient stirring and centrifugation at 860×g 
for 60min,  the cells were overlaid with agarose 
medium consisting of 10ｵ FBS-DMEM containing 
1µg/ml of cycloheximide and 0.5ｵ agarose (SeaKem 
ME agarose; FMC BioProducts,  Rockland,  ME,  
USA).  After solidiﬁcation,  the liquid medium,  which 
was prepared by omitting agarose from the agarose 
medium,  was added and incubated at 37℃ in a 5ｵ 
CO2 incubator.  The liquid medium was exchanged 
every 4 to 5 days.  At an appropriate time after infec-
tion,  the liquid medium was removed,  and agarose 
medium containing 0.03ｵ (ﬁnal concentration) of 
neutral red was loaded on the agarose medium.  After 
incubation at 37℃ for 12 to 15h,  single plaques with 
suﬃcient separation from each other were recovered 
with agar-well punchers commonly used to make holes 
in the Ouchterlony immunodiﬀusion test.  Each aga-
rose plug placed in 1ml of SPG buﬀer was sonicated 
and centrifuged at 300×g for 5min,  and the superna-
tant was inoculated onto McCoy cells as described 
above.  To purify each strain,  this procedure was 
repeated three times.
　 In vitro drug susceptibility. The antimicro-
bial agents tested were clarithromycin (Taisho 
Pharmaceutical,  Tokyo,  Japan),  minocycline (Wyeth 
Lederle,  Tokyo,  Japan) and tosuﬂoxacin (Toyama 
Chemical,  Tokyo,  Japan).  The agents were dissolved 
by the master dilution method.  MICs of chlamydial 
strains obtained by plaque puriﬁcation were deter-
mined by the standard method of the Japan Society of 
Chemotherapy [13].  Brieﬂy,  HeLa 229 cell conﬂu-
ent monolayers prepared on cover slips placed in 
24-well culture plate were inoculated with chlamydial 
suspension at 1,000 IFU/well by centrifugation (860
×g,  60min).  After centrifugation,  1ml of culture 
medium,  consisting of Eagleʼs MEM,  10ｵ heat-inac-
tivated FBS,  and cycloheximide,  at a ﬁnal concentra-
tion of 1µg/ml was applied.  The medium also con-
tained one concentration of the antimicrobial agents.  
Then,  the plates were incubated at 37℃ in an atmo-
sphere of 5ｵ CO2 for 48h.  After ethanol ﬁxation,  
the infected cells were stained with DFA and the 
inclusions were observed.  The MIC was deﬁned as the 
lowest concentration at which inclusion formation was 
completely inhibited.
　 Puriﬁcation of EBs. EBs of puriﬁed strains 
and laboratory strains,  such as C. caviae GPIC (VR-
813,  obtained from the American Type Culture 
Collection,  Manassas,  VA,  USA),  C. trachomatis 
biovars D and L2,  and C. psittaci Cal 10 were pre-
pared by the method reported previously [7].  
Infected McCoy cells with well-developed inclusions 
were sonicated to facilitate the release of chlamydial 
organisms from the host cells.  After brief centrifuga-
tion at 300×g for 10min to remove large debris,  the 
supernatant was subjected to 25ｵ sucrose-cushioning 
centrifugation (8,000×g,  4℃,  60min),  and then the 
suspension was incubated with DNase (20µg/ml) and 
RNase (20µg/ml) in a water bath at 37℃ for 60min,  
followed by treatment with trypsin (10µg/ml) at 37℃ 
for 60min.  Similarly,  EBs of C. pneumoniae TW183 
were prepared from HEp2 cells having well-grown 
inclusions.  After sonication to disperse large aggre-
gates,  the suspension was subjected to 25ｵ sucrose-
cushioning centrifugation again.  The sediment was 
suspended in SPG buﬀer and used for the extraction 
of genomic DNA.
　 MOMP gene sequencing. The Puregene DNA 
puriﬁcation kit (Gentra System,  Minneapolis,  MN,  
USA) was used for genomic DNA extraction from 
puriﬁed EBs of each strain.  PCR was performed 
under the conditions shown in Table 1 using genomic 
DNA as a template and the primers reported by 
Kaltenboeck et al.  [14] to amplify the entire MOMP 
gene of strains,  namely OK135 and SC10-6,  obtained 
through plaque puriﬁcation.  The resulting ampliﬁca-
tion products were cleaned using MagExtractor 
(Toyobo,  Osaka,  Japan),  and the BigDye terminator 
3Chlamydophila caviae-like Chlamydia from Human SourcesFebruary 2010
3
Murao et al.: Epidemiology of Chlamydophila caviae-like Chlamydia Isolated from
Produced by The Berkeley Electronic Press, 2010
cycle sequencing FS ready reaction kit (Applied 
Biosystems Japan,  Tokyo,  Japan) was used to make 
sequencing templates.  The ABI 310 Genetic Analyzer 
(Applied Biosystems Japan) was used to determine the 
MOMP gene of each strain,  and a BLAST search was 
used to investigate the homology of the sequence in the 
MOMP genes with that of the standard strain,  C. 
caviae GPIC [15].
　 Molecular diagnosis of clinical specimens.
Based on the nucleotide sequence data of the MOMP 
gene of the OK135 clone,  primers (2 pairs) speciﬁc to 
the ompA gene of the same strain were designed 
(Table 1).  The expected ampliﬁcation product of 
nested PCR using these primer sets was a 311-bp 
DNA fragment.  The genomic DNA of each strain was 
prepared from puriﬁed EBs with the QIAamp DNA 
stool mini kit (QIAGEN,  Tokyo,  Japan).  Under the 
conditions shown in Table 1,  5µl of template and 45µl 
of reaction solution were added (10×buﬀer,  0.2mM 
dNTPs,  0.625U Taq polymerase (TaKaRa,  Shiga,  
Japan) and 0.2µM primer) for a total volume of 50µl 
to perform nested PCR using Astec PC 801 thermal 
cycler.  The resulting PCR product was subjected to 
electrophoresis using 1.2ｵ agarose gel in relation to 
a 100-bp DNA ladder (New England Biolabs Japan,  
Tokyo,  Japan) as a molecular standard,  and the 311-
bp band was examined.
　 In addition to the chlamydial culture,  all swab 
specimens,  from 119 male and 83 female subjects,  
were examined with the commercially available PCR 
test kit (AMPLICOR Chlamydia trachomatis: Roche 
Diagnostics K.K.,  Tokyo,  Japan) for C. trachomatis 
and the PCR test kit (AMPLICOR Neisseria 
gonorrhoeae; Roche Diagnostic K.K. ) for N. gonor-
rhoeae or gonococcal cultures.  When the microscopic 
examinations were positive but the PCR for C. tracho-
matis was undetermined,  nested PCR,  for which 2 
pairs of primers speciﬁc to the ompA gene of OK135 
were especially designed,  was carried out (Table 1).  
For the male samples,  Mycoplasma genitarium,  Myco-
plasma hominis,  Ureaplasma urealyticum and Ureaplasma 
parvum were also examined with the multiplex PCR 
test kit (Mitsubishi Chemical Medience Corp.,  Tokyo,  
Japan) to conﬁrm a solo infection with the chlamydial 
strain identical with OK135.  Such tests were,  how-
ever,  not subjected to the female samples because of 
their heavier contamination with other microorgan-
isms.
Results
　 Morphology of chlamydial strains obtained by 
the plaque puriﬁcation. In the preliminary DFA 
test,  the inclusions formed from swab specimens of 3 
patients,  OKM2,  OK133 and OK135 were noted their 
morphology.  Therefore,  these isolates were examined 
with staining methods in detail.  It was suggested 
strongly that the swab specimen of the OKM2 patient 
contained,  at least,  2 diﬀerent Chlamydia species.  To 
separate and purify each strain,  the plaque formation 
was carried out successively,  and 2 strains,  SC10-6 
and ST13-6-1,  were obtained.  The inclusions of 
ST13-6-1 were round or oval in shape (Fig.  1B) while 
those of SC10-6 were irregular (Fig.  1A).  Simul-
taneously,  many small particles showing speciﬁc 
stainability with DFA were scattered on the cell lay-
ers,  suggesting that the particles were chlamydial 
bodies resulted from an inclusion burst.  Conse-
quently,  it was likely that the strain SC10-6 grew 
rapidly.  Fig.  2 shows the iodine-stained images of 
both SC10-6 and ST13-6-1 strains.  The ST13-6-1 
inclusions at 48h post-inoculation were intensely 
stained (Fig.  2B),  indicating glycogen accumulation.  
The stainability,  together with the round-shaped 
inclusion morphology in the DFA test,  indicated that 
the ST13-6-1 strain was undoubtedly a member of the 
C. trachomatis species.  By contrast,  the SC10-6 inclu-
sions were not stained even after 48h post-inoculation 
4 Acta Med.  Okayama　Vol.  64,  No.  1Murao et al.
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(Fig.  2A).  This result,  together with the inclusion 
morphology and the presence of scattered chlamydial 
bodies in the DFA test,  indicated that the SC10-6 
strain was diﬀerent from C. trachomatis.  Additionally,  
the ST13-6-1 strain reacted positively with the PCR 
test kit while SC10-6 did not.
　 Determination of the species of SC10-6 and 
OK135 strains. To determine the species of 
SC10-6 and OK135 strains,  the ompA gene was ampli-
ﬁed from puriﬁed EBs of each strain and its nucle-
5Chlamydophila caviae-like Chlamydia from Human SourcesFebruary 2010
Ａ：SC10-6 Ｂ：ST13-6-1
Fig. 1　 Fluorescent images of SC10-6 (A) and ST13-6-1 (B),  2 clones from OKM2 (a male patient with urethritis).  DFA staining with 
genus-speciﬁc ﬂuorescein-conjugated monoclonal antibody was used.  Inclusions of ST13-6-1 were of the typical round shape, indicating C. 
trachomatis,  but those of SC10-6 had irregular borders,  and numerous lysed cells were seen at 48h post-inoculation.
Ａ：SC10-6 Ｂ：ST13-6-1
Fig. 2　 Iodine staining for SC10-6 (A) and ST13-6-1 (B) infected cells.  Inclusions of ST13-6-1 stained brown,  indicating glycogen 
accumulation associated with C. trachomatis.  However,  inclusions of SC10-6 were not stained,  and no glycogen accumulation was con-
ﬁrmed.
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otide sequence was analyzed.  The results revealed 
that the nucleotide sequences of ompA gene of both 
strains,  SC10-6 and OK135,  were exactly the same,  
that their ompA genes were highly homologous to the 
nucleotide sequence (99.0ｵ) of the ompA gene in C. 
caviae GPIC,  and that their putative 389-amino-acid 
sequences were exactly the same as that of OmpA in 
C. caviae GPIC.  Therefore,  it was concluded that 
OKM2 and OK135 patients were infected with 2 dif-
ferent species of chlamydiae; one was a typical C. 
trachomatis strain and the other was an unusual chla-
mydial species in human urogenital infections,  C. 
caviae-like Chlamydia.  Although the analysis of the 
ompA gene was not done for OK133,  its phenotypic 
characteristics were quite similar to those of other two 
C. caviae-like Chlamydia strains,  and the result 
obtained in nested PCR conﬁrmed that OK133 was 
also C. caviae-like Chlamydia (see below).
　 Drug susceptibility of C. caviae-like 
Chlamydia. Determination of drug susceptibility 
of the strains SC10-6 and OK135 was requested by 
physicians at the clinics where the patients OKM2 and 
OK135 were medicated,  because of their poor 
response to antichlamydial chemotherapy.  The drug 
susceptibility of the strains,  together with the ST13-6 
strain and C. trachomatis serover D,  were tested.  The 
MIC values obtained for clarithromycin,  minocycline 
and tosuﬂoxacin were 0.016,  0.016 to 0.031 and 
0.25µg/ml,  respectively; no diﬀerence in the MIC 
value was detected between the 2 strains.  Addition-
ally,  there was no marked diﬀerence from the stan-
dard C. trachomatis serovar D.  Based on the results,  
it was very likely that the patientʼs poor response to 
chemotherapy was not a result of the chlamydial prop-
erties,  but might have been due to in vivo drug circu-
lation into histopathological regions in the patients.
　 Epidemiological analysis. The fact that the 
patients were dually infected with either SC10-6 or 
OK135 and C. trachomatis strains impelled us to inves-
tigate whether C. caviae-like Chlamydia was a patho-
genic agent of human STI,  and if so,  whether C. 
caviae-like Chlamydia is widespread.  Genomic DNA 
was extracted from puriﬁed EBs of OK133,  OK135,  
SC10-6,  C. caviae GPIC,  C. trachomatis serovar D and 
L2,  C. psittaci Cal 10 and C. pneumoniae TW183.  
Using extracted DNA,  the nested PCR assay,  
designed on the basis of the ompA sequence of the 
OK135 strain,  was performed as shown in Table 1,  
and a 311-bp ampliﬁcation product was observed for 
OK133,  OK135,  SC10-6 and C. caviae GPIC (Fig.  
3).  The results demonstrate that this nested PCR 
assay was speciﬁc to C. caviae GPIC and C. caviae-like 
Chlamydia,  and that OK133,  OK135 and SC10-6 
were all C. caviae-like Chlamydia.  This suggests that 
the nested PCR assay speciﬁc to C. caviae GPIC can 
be used in epidemiological studies.
6 Acta Med.  Okayama　Vol.  64,  No.  1Murao et al.










Fig. 3　 Electrophoresis of ampliﬁcation products obtained by nested PCR assay which was performed using two pairs of primers speciﬁc 
to the ompA gene of C. caviae-like Chlamydia OK135 (Table 1).  Electrophoresis was conducted using 1.2% agarose gel and a 100-bp 
DNA ladder as a molecular standard.  The expected ampliﬁcation product was a 311-bp DNA fragment.
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　 Based on the results,  the nested PCR assay was 
performed on swab specimens obtained from a total of 
202 patients,  including 119 male patients with ure-
thritis and 83 female patients with either cervicitis or 
suspected STI from July,  2003 to December,  2006.  
In each patient,  the presence or absence of N. gonor-
rhoeae (117 male and 83 female patients tested),  C. 
trachomatis (114 male and 83 female patients tested) 
and C. caviae-like Chlamydia (all 202 patients tested) 
was determined (Fig.  4).  Of the 119 male patients 
with urethritis,  34 had N. gonorrhoeae,  33 had C. tra-
chomatis,  and 8 had both N. gonorrhoeae and C. tracho-
matis.  With regard to the 83 female patients,  45 
asymptomatic patients underwent tests for sexually 
transmitted diseases after becoming pregnant or 
changing partners,  and the other 38 patients had 
cervicitis-related symptoms,  such as increased dis-
charge,  abnormal color and vaginal erosion.  Of the 
83 female patients,  2 had N. gonorrhoeae,  15 had C. 
trachomatis,  and 1 patient had both N. gonorrhoeae and 
C. trachomatis.  To determine the infection of C. caviae-
like Chlamydia,  the nested PCR assay was carried out 
as mentioned above; the results are summarized in 
Fig.  4.  Among 14 male patients,  including OKM2,  
who were positive for C. caviae-like Chlamydia,  7 had 
C. trachomatis,  4 had N. gonorrhoeae,  and 1 had both N. 
gonorrhoeae and C. trachomatis.  On the other hand,  
among the 4 female patients positive for C. caviae-like 
Chlamydia,  2 had C. trachomatis.  In other words,  C. 
caviae-like Chlamydia,  with neither C. trachomatis nor 
N. gonorrhoeae,  was detected in a total of 6 patients (4 
male and 2 female patients).  Table 2 summarizes the 
clinical backgrounds of the 20 patients who were 
positive for C. caviae-like Chlamydia,  including OK133 
and OK135.  Eleven of the 14 male patients had ure-
thritis-related symptoms,  such as pain on urination 
and pus discharge,  and 2 of the 6 female patients had 
cervicitis-related symptoms.  In most patients,  symp-
toms improved after chemotherapy.  However,  in case 
OK135,  symptoms did not improve and intractable 
cervicitis developed,  and in cases 9,  13 and 14,  
symptoms such as pain on urination continued even 
after chemotherapy.  M. genitalium was detected in the 
male patients (cases 9,  10,  13 and 14) who were posi-
tive for C. caviae-like Chlamydia and negative for C. 
trachomatis and N. gonorrhoeae.  In the female cases 11 
and 12,  the presence or absence of Mycoplasma and 
Ureaplasma spp.  was not tested.
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Fig. 4　 C. trachomatis,  N. gonorrhoeae and C. caviae-like Chlamydia infections are summarized for the 119 male and 83 female patients 
tested. In each patient,  the presence or absence of N. gonorrhoeae (117 male and 83 female patients tested),  C. trachomatis (114 male 
and 83 female patients tested) and C. caviae-like Chlamydia (all 202 patients tested) was determined.  C. caviae-like Chlamydia was 
detected in 14 male and 4 female patients,  including OK133 and OK135,  which were isolated in 2000; a total of 20 C. caviae-like 
Chlamydia strains were isolated from 2000 to 2006.
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Discussion
　 The results obtained in the present study revealed 
the presence of novel chlamydial strains that were 
undetectable with the PCR or LCR commonly used for 
diagnosis of C. trachomatis infection and that closely 
resembled C. caviae.  C. caviae GPIC is well known as 
an etiologic agent in guinea pigs,  but to the best of our 
knowledge,  there have been no reports of isolated C. 
caviae or similar chlamydial strain from humans.  How 
then was C. caviae-like Chlamydia isolated from the 
male urethra and cervical canal? No conclusive evi-
dence on this point has been obtained.  At the moment,  
it is speculated that C. caviae-like Chlamydia has been 
transmitted and colonized in the human pharynx or 
sexual organs through close contact with guinea pigs,  
and that sexual acts,  including oral sex,  can spread 
the organism from human to human.  Such a specula-
tion seems to be supported by the facts that other 
Chlamydophila,  such as C. abortus and C. felis,  regar-
ded for a long time as animal- restricted pathogens,  
were revealed to be the causes of chlamydial abortion 
[16,  17] and conjunctivitis [18-20] in humans who 
might have been infected through close contact with 
carrier and/or infected animals.  During transmission 
and colonization of C. caviae-like Chlamydia,  genetic 
variations appeared to occur,  because the homology of 
the ompA gene of this strain to the GPIC strain was 
very high but not identical.  This fact leads us to 
speculate that several genes,  not only the gene encod-
ing MOMP but also other genes encoding functional 
proteins,  have evolved to be stable during their trans-
mission and multiplication in humans.  Thus,  it will be 
necessary to sequence the whole genome of C. caviae-
like Chlamydia in the future.
　 Using the nested PCR assay speciﬁc to C. caviae-
like Chlamydia,  the organism was detected in a total 
of 18 patients.  Of these patients,  C. trachomatis and 
N. gonorrhoeae were detected in 9 and 4 patients,  
respectively,  with one patient having both.  Thus,  C. 
caviae-like Chlamydia,  with neither C. trachomatis nor 
N. gonorrhoeae,  was detected in a total of 6 patients (4 
male and 2 female patients).  However,  additional 
diagnostic tests detected M. genitalium in the 4 male 
patients.  The samples of the 2 female patients were 
not tested because of possible genital contamination by 
microorganisms.  Therefore,  we cannot state conclu-
sively that C. caviae-like Chlamydia is pathogenic for 
humans; the organism appeared to be rather common 
(positive percentage was 8.9ｵ).
　 In general,  chlamydial isolations should be done 
prior to antibiotic medication; fortunately,  we man-
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number of C. caviae-like 
Chlamydia
OK133 2000 female 20 nothing special ＋ － ＋ OK133
OK135 2000 female 27 leukorrhea ＋ － ＋ OK135
1 OKM2 2003. 07. 01 male 34 pus discharge ＋ － ＋ SC10-6
2 OKM10 2004. 01. 08 male 20 pain on urination ＋ － ＋ no cloning
3 OKM11 2004. 01. 26 male 29 inguinal pain ＋ － ＋ no cloning
4 OKM13 2004. 02. 17 male 29 nothing special ＋ － ＋ no cloning
5 OKM52 2005. 06. 18 female 33 leukorrhea ＋ － ＋ no cloning
6 OKM59 2005. 08. 08 male 44 residual urine ＋ － ＋ no cloning
7 OKM75 2005. 10. 14 male 21 pain on urination － ＋ ＋ no cloning
8 OKM88 2005. 11. 30 female 20 nothing special ＋ － ＋ no cloning
9 OKM96 2006. 02. 13 male 36 pain on urination,  pus discharge － － ＋ no cloning
10 OKM98 2005. 12. 16 male 44 NR － － ＋ no cloning
11 OKM104 2006. 02. 15 female NR check for STI － － ＋ no cloning
12 OKM109 2006. 01. 05 female NR check for STI － － ＋ no cloning
13 OKM112 2006. 03. 02 male 21 pain on urination － － ＋ no cloning
14 OKM116 2006. 03. 13 male NR pain on urination,  pyuria － － ＋ no cloning
15 OKM136 2006. 06. 24 male NR pain on urination,  pus discharge ＋ － ＋ no cloning
16 OKM147 2006. 08. 18 male 30 pain on urination,  pus discharge ＋ ＋ ＋ no cloning
17 OKM185 2006. 10. 31 male 43 pus discharge － ＋ ＋ no cloning
18 OKM202 2006. 12. 09 male 24 pus discharge － ＋ ＋ no cloning
NR: no records
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aged to isolate strains OK135 and SC10-6 through the 
McCoy cell after anti-chlamydial medication.  In spite 
of the poor response in vivo and the rapid growth in 
vitro,  the puriﬁed strains of C. caviae-like Chlamydia 
were susceptible to drugs such as clarithromycin,  
minocycline and tosuﬂoxacin at similar levels as other 
chlamydiae.  It is therefore concluded that the failure 
of chemotherapy was due to reduced drug circulation 
into histopathological regions in the patients.  This 
ﬁnding should be a warning that the drug susceptibil-
ity of chlamydiae should be determined using organ-
isms isolated from unresponsive patients; otherwise,  
the drug eﬃcacy can be misunderstood.
　 Recently,  we have started to collect pairs of 
samples: from the throat and urethra for men and from 
the throat and uterine cervix for women.  These stud-
ies are expected to clarify the prevalence of infection 
with C. caviae-like Chlamydia as an STI,  as well as its 
pathogenicity.  Because urethritis or cervicitis caused 
solely by C. caviae-like Chlamydia has not been 
reported,  further investigations are needed to deter-
mine its pathogenicity in humans.  It will also be nec-
essary to investigate the possibility of C. caviae-like 
Chlamydia causing nongonococcal/nonchlamydial ure-
thritis or cervicitis,  intrapelvic peritonitis,  or infer-
tility.
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